Agronomics Boosts Stake in Precision Fermentation Firm All G with AU$3 Million Note Investment

Agronomics ( (GB:ANIC) ) has provided an announcement.

Agronomics has invested a further AU$3 million in Australian biotech All G, which uses precision fermentation to produce human and bovine milk proteins, notably animal‑free lactoferrin for applications in infant and clinical nutrition, functional foods, skincare and animal nutrition. The funding, made via a convertible note as part of a wider AU$10 million round and settled through the issue of 10,026,375 new Agronomics shares, will support All G’s commercial‑scale production, regulatory work and expansion in Asia and Europe after it secured pioneering approvals for recombinant bovine lactoferrin in China and self‑affirmed GRAS status in the US; post‑transaction, Agronomics’ total investment in All G rises to about £8.9 million and its own share capital increases to 1,056,575,208 shares, with potential implications for shareholder notifications under disclosure rules.

The most recent analyst rating on (GB:ANIC) stock is a Hold with a £6.00 price target. To see the full list of analyst forecasts on Agronomics stock, see the GB:ANIC Stock Forecast page.

Spark’s Take on GB:ANIC Stock

According to Spark, TipRanks’ AI Analyst, GB:ANIC is a Neutral.

The score is weighed down primarily by weak financial performance (recent losses and persistently negative cash flow), with technicals also bearish (price below key moving averages and negative MACD). Valuation is additionally constrained by a negative P/E driven by losses and no dividend data to offset risk; the main positive is the debt-free balance sheet, though equity has been eroding.

To see Spark’s full report on GB:ANIC stock, click here.

More about Agronomics

Agronomics is a London-listed investment company focused on cellular agriculture, backing more than 20 businesses developing alternative ways to produce food and materials traditionally derived from animals. Its portfolio targets technologies that improve sustainability, human health and food security, positioning the firm as a specialist investor in next‑generation protein and biomaterial production.

Average Trading Volume: 1,812,590

Technical Sentiment Signal: Sell

Current Market Cap: £62.79M

See more data about ANIC stock on TipRanks’ Stock Analysis page.